Efficacy of combined interferon and ribavirin for treatment of hepatitis C

Lancet

Volumn 351, Issue 9096, 1998, Pages 78-79

  Brown, J L ^a  

^a CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; AMINOTRANSFERASE; HEMOGLOBIN; RIBAVIRIN;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG COST; DRUG EFFICACY; HEMOLYSIS; HEPATITIS C; HUMAN; LIFESPAN; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME;

EID: 0032501729     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78157-5     Document Type: Note

References (19)

1. J Hoofnagle K Mullen D Jones Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon N Engl J Med 315 1986 1575 1578
2. K Kiyosawa T Sodeyama E Tanaka Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus Hepatology 12 1990 671 675
3. MJ Tong NS El-Farra AR Reikes RL Co Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332 1995 1463 1466
4. T Poynard P Bedossa P Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349 1997 825 832
5. J Power F Davidson J O'Riordan P Simmonds P Yap E Lawlor Hepatitis C infection from anti-D immunoglobulin Lancet 346 1995 372 373
6. S Dittmann M Roggendorf J Durkop M Wiese B Lorbeer F Deinhardt Long-term persistence of hepatitis C virus antibodies in a single source outbreak J Hepatol 13 1991 323 327
7. J Crowe C Doyle J Fielding Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation Gastroenterology 108 1995 1054A
8. LB Seeff Z Buskell-Bales EC Wright Long-term mortality after transfusion-associated non-A, non-B hepatitis N Engl J Med 327 1992 1906 1911
9. W Bennet Y Inoue R Beck J Wong S Paulker G Davis Estimates of cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 127 1997 855 865
10. R Kim J Poterucha J Hermans Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis C. Ann Intern Med 127 1997 866 874
11. P Marcellin N Boyer A Gervais Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-α therapy Ann Intern Med 127 1997 875 881
12. O Reichard J Andersson R Schvarcz O Weiland Ribavirin treatment for chronic hepatitis C Lancet 337 1991 1058 1061
13. S Schalm B Hansen L Chemello Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers J Hepatol 26 1997 961 966
14. L Chemello L Cavaletto E Bernardinello M Guido P Pontisso A Alberti The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C J Hepatol 23 1995 8 12
15. M-Y Lai J-H Kao P-M Yang Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C Gastroenterology 111 1996 1307 1312
16. X Wei S Ghosh M Taylor Viral dynamics in human immunodeficiency virus type 1 infection Nature 373 1995 117 122
17. D Ho A Neumann A Perelson W Chen J Leonard M Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 1995 123 126
18. N Lam A Neumann D Gretch T Wiley A Perelson T Layden Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Hepatology 26 1997 226 231
19. M Kozal N Shah N Shen Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays Nat Med 2 1996 753 759